HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paul Matthias Diderichsen Selected Research
Paul Matthias Diderichsen Research Topics
Disease
3
Neoplasms (Cancer)
01/2023 - 01/2022
2
Chronic Obstructive Pulmonary Disease (COPD)
11/2013 - 06/2013
1
Squamous Cell Carcinoma of Head and Neck
09/2023
1
Hematologic Neoplasms (Hematological Malignancy)
01/2023
1
Body Weight (Weight, Body)
01/2022
1
Idiopathic Pulmonary Fibrosis
01/2019
1
Crohn Disease (Crohn's Disease)
08/2015
1
Rheumatoid Arthritis
08/2015
1
Asthma (Bronchial Asthma)
06/2013
Drug/Important Bio-Agent (IBA)
2
simurosertib
IBA
01/2022 - 01/2022
2
Phosphotransferases (Kinase)
IBA
01/2022 - 01/2022
2
N- ((4'- hydroxybiphenyl- 3- yl)methyl)- 2- (3- (2- ((- 2- hydroxy- 2- (4- hydroxy- 3- ((methylsulfonyl)amino)phenyl)ethyl)amino)- 2- methylpropyl)phenyl)acetamide
IBA
11/2013 - 06/2013
1
Inhibitor of Apoptosis Proteins
IBA
09/2023
1
Cisplatin (Platino)
FDA Link
Generic
09/2023
1
fms-Like Tyrosine Kinase 3
IBA
01/2023
1
Syk Kinase
IBA
01/2023
1
Creatinine
IBA
01/2022
1
GLPG1690
IBA
01/2019
1
lysophosphatidic acid
IBA
01/2019
1
Rifampin (Rifampicin)
FDA Link
Generic
01/2019
1
Janus Kinase 1
IBA
08/2015
1
GLPG0634
IBA
08/2015
1
Adrenergic Receptors (Adrenergic Receptor)
IBA
11/2013
Therapy/Procedure
1
Radiotherapy
09/2023
1
Chemoradiotherapy
09/2023
1
Oral Administration
01/2022